Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIb Multicenter Randomized Comparative Study of Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for Chronic Inflammatory Bowel Disease

NCT02255227 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Saint Etienne as lead sponsor.

NCT NCT02255227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02255227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIb Multicenter Randomized Comparative Study of Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for Chronic Inflammatory Bowel Disease
Lead sponsor
Centre Hospitalier Universitaire de Saint Etienne
Phase
Phase 2
Overall status
Terminated
Start date
April 13, 2015
Completion date
July 6, 2022
Enrollment
104 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

bowel diseases, inflammatory, infections, pneumococcal